2019—2021年天津市宝坻区人民医院保肝药物使用情况分析  

Analysis on the use of hepatoprotective drugs in Tianjin Baodi Hospital from 2019 to 2021

作　　者：庄俊雪 潘霖[2] ZHUANG Jun-xue;PAN Lin(Tianjin Baodi Hospital,Baodi Clinical College of Tianjin Medical University,Tianjin 301800,China;Tianjin First Center Hospital,Tianjin 300192,China)

机构地区：[1]天津市宝坻区人民医院天津医科大学宝坻临床学院,天津301800 [2]天津市第一中心医院,天津300192

出　　处：《现代药物与临床》2022年第4期864-868,共5页Drugs & Clinic

摘　　要：目的统计分析2019—2021年天津市宝坻区人民医院保肝药物的使用情况,分析其使用趋势,为医院保肝药物的科学管理和临床合理用药提供参考。方法采用世界卫生组织推荐的限定日剂量(DDD)分析方法,计算每种保肝药物的用药频度(DDDs)、日均费用(DDC),并对药物的销售金额和DDDs分别进行排序,计算其排序比(B/A)。结果天津市宝坻区人民医院保肝药物以口服剂型为主,销售金额与用药频度排序比接近1、大于1的品种逐年增多,且使用频度排名前3位的药物DDC均小于10元。结论天津市宝坻区人民医院临床对于保肝药物的选择在保证疗效的基础上更加倾向于价格偏低的品种,符合安全、有效、经济的用药原则。Objective To statistically analyze the use of hepatoprotective drugs in Tianjin Baodi Hospital from 2019 to 2021,and analyze their use trend,so as to provide reference for the scientific management and clinical rational use of liver protecting drugs in the hospital.Methods Using the analysis method of defined daily dose(DDD)recommended by the World Health Organization(WHO),the medication frequency(DDDs)and average daily cost(DDC)of each hepatoprotective drugs were calculated,and the sales amount and DDDs of drugs were ranked,respectively,and the ranking ratio was calculated.Results The hepatoprotective drugs are mainly oral dosage forms.The ranking ratio of sales amount to medication frequency is close to 1,and the varieties greater than 1 are increasing year by year,and the DDC of the top three drugs ranked in the frequency of use is less than 10 yuan.Conclusion On the basis of ensuring the curative effect,the clinical choice of hepatoprotective drugs in Tianjin Baodi Hospital is more inclined to the varieties with low price,which is in line with the principle of safe,effective and economic drug use.

关 键 词：保肝药物 限定日剂量 销售金额 用药频度 日均费用 

分 类 号：R975[医药卫生—药品]